Acute Pancreatitis Market Report 2026

Acute Pancreatitis Market Overview

• Acute Pancreatitis market size has reached to $6.29 billion in 2025 • Expected to grow to $8.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Increasing Healthcare Expenditure Fuels Growth In The Acute Pancreatitis Market • Market Trend: Advancements In Acute Pancreatitis Diagnosis Driven By Innovative Technologies • North America was the largest region in 2025.

What Is Covered Under Acute Pancreatitis Market?

Acute pancreatitis refers to a medical condition in which the pancreas becomes inflamed and enlarged during a brief period of acute pancreatitis. It is caused due to gallstones or drinking too much alcohol. The main causes of acute pancreatitis are gallstones, alcohol, and others. Gallstones refer to bile deposits that have solidified and can develop in the gallbladder. Gallstone causes pain and inflammation of the pancreas when a gallstone obstructs your pancreatic duct leading to acute pancreatitis. The various treatment for acute pancreatitis include intravenous fluid, nutritional support, analgesics, endoscopic retrograde cholangiopancreatography (ECRP), and others and they are diagnosed through imaging tests and laboratory tests by hospitals, clinics, and others.

What Is The Acute Pancreatitis Market Growth Forecast?

The acute pancreatitis market size is expected to see strong growth in the next few years. It will grow to $8.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to development of targeted therapeutic interventions, rising awareness of lifestyle modifications, adoption of minimally invasive treatments, growth in hospital and clinic capacities, integration of advanced diagnostic technologies. Major trends in the forecast period include rising incidence of gallstone and alcohol-induced pancreatitis, increased use of advanced imaging and laboratory diagnostic tests, growing adoption of intravenous fluid and nutritional support treatments, expansion of minimally invasive procedures like ercp, enhanced focus on early detection and patient management strategies.

Global Acute Pancreatitis Market Segmentation

1) By Cause: Gallstones, Alcohol, Other Causes 2) By Treatment: Intravenous Fluid, Nutritional Support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP), Other treatments 3) By Diagnosis: Imaging tests, Laboratory Tests Subsegments: 1) By Gallstones: Cholecystitis-Induced Pancreatitis, Choledocholithiasis-Induced Pancreatitis 2) By Alcohol: Acute Alcoholic Pancreatitis, Binge Drinking-Induced Pancreatitis 3) By Other Causes: Medications-Induced Pancreatitis, Trauma-Induced Pancreatitis, Infections-Induced Pancreatitis

What Is The Driver Of The Acute Pancreatitis Market?

Increasing healthcare expenditure is expected to propel the growth of the acute pancreatitis market going forward. Healthcare expenditure refers to the total amount of resources, including financial and non-financial, consumed in the provision of health services and related activities. Increasing healthcare expenditure can be attributed to several factors, including the prevalence of chronic diseases, the expansion of health insurance coverage, and the growing awareness of mental health issues. Acute pancreatitis can lead to severe complications such as necrotizing pancreatitis, organ failure, and infections, necessitating additional treatments, surgeries, and prolonged hospital stays, which significantly escalate healthcare costs. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, total health expenditure is projected to reach $344 billion in 2023, reflecting a modest growth of 2.8% compared to the previous year. Therefore, increasing healthcare expenditure is driving the growth of the acute pancreatitis industry.

Key Players In The Global Acute Pancreatitis Market

Major companies operating in the acute pancreatitis market are CalciMedica Inc., SCM Lifescience Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Medtronic plc, Boston Scientific Corporation, Fresenius Kabi AG, Sun BioPharma Inc., Atox Bio Inc., D-Pharm Ltd., Olympus Corporation, Abbott Laboratories, Pfizer Inc., Merck & Co Inc., GlaxoSmithKline plc, AbbVie Inc., Amgen Inc., AstraZeneca PLC, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Novartis AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Johnson & Johnson

Global Acute Pancreatitis Market Trends and Insights

Major companies operating in the acute pancreatitis market are developing advanced technologies, such as dry chemistry slide technology, to measure pancreatic lipase levels accurately. Dry chemistry slide technology is a diagnostic method that uses a coated slide with dry reagents to perform chemical reactions for analyzing biological samples, enabling rapid and accurate testing without the need for liquid reagents. For instance, in June 2024, IDEXX Laboratories Inc., a US-based diagnostics and healthcare innovation company, introduced the catalyst pancreatic lipase test for diagnosing pancreatitis in dogs and cats, utilizing dry chemistry slide technology for accurate measurement of pancreatic lipase levels. The test provides rapid, quantitative results in under 10 minutes and integrates seamlessly with existing workflows, enhancing diagnostic efficiency. This test aims to improve early diagnosis and treatment of pancreatitis, a critical condition in pets, and will be supported by future developments such as the Catalyst SmartQC Control to further streamline veterinary diagnostics.

What Are Latest Mergers And Acquisitions In The Acute Pancreatitis Market?

In March 2023, CalciMedica Inc., a US-based biopharmaceutical company, merged with Graybug Vision for an undisclosed amount. The aim of the merger is to enhance the development of CalciMedica's lead product candidate Auxora for treating life-threatening inflammatory diseases, particularly acute pancreatitis, by combining resources and expertise. Graybug Vision Inc. is a US-based biopharmaceutical company that focused on developing innovative therapies for ocular diseases.

Regional Outlook

North America was the largest region in the acute pancreatitis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Pancreatitis Market?

The acute pancreatitis market includes revenues earned by entities by providing therapies, medications, and procedures aimed at managing and treating the condition. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Acute Pancreatitis Market Report 2026?

The acute pancreatitis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the acute pancreatitis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.